NexImmune, Inc. (NEXI) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 2 recommend buying, 2 recommend holding, and 0 recommend selling.
The analyst consensus price target for NEXI is $3.33, representing a +3,329,900.0% upside from the current price of $0.0001. Price targets range from a low of $2.00 to a high of $5.00.
